Cargando…

“Population structure of drug-susceptible,—resistant and ESBL-producing Escherichia coli from community-acquired urinary tract”

BACKGROUND: Escherichia coli is the most common cause of urinary tract infection (UTI). The pathogenic isolates are becoming increasingly resistant to antibiotics; with a worldwide dissemination of resistant sequence types (ST). We characterized three different uropathogenic E. coli populations, fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hertz, Frederik Boëtius, Nielsen, Jesper Boye, Schønning, Kristian, Littauer, Pia, Knudsen, Jenny Dahl, Løbner-Olesen, Anders, Frimodt-Møller, Niels
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827192/ https://www.ncbi.nlm.nih.gov/pubmed/27067536 http://dx.doi.org/10.1186/s12866-016-0681-z

Ejemplares similares

Erratum to: Population structure of Drug-Susceptible,—Resistant and ESBL-producing Escherichia coli from community-acquired urinary tract infections
por: Hertz, Frederik Boëtius, et al.
Publicado: (2016)

Mutational change of CTX‐M‐15 to CTX‐M‐127 resulting in mecillinam resistant Escherichia coli during pivmecillinam treatment of a patient
por: Nielsen, Karen Leth, et al.
Publicado: (2019)

Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study
por: Jansåker, Filip, et al.
Publicado: (2019)

Escherichia coli belonging to ST131 rarely transfers bla(ctx-m-15) to fecal Escherichia coli
por: Thingholm, Karen Rønø, et al.
Publicado: (2019)

Growth Rate of Escherichia coli During Human Urinary Tract Infection: Implications for Antibiotic Effect
por: Haugan, Maria Schei, et al.
Publicado: (2019)

Synergy between Mecillinam and Ceftazidime/Avibactam or Avibactam against Multi-Drug-Resistant Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae
por: List, Karoline Knudsen, et al.
Publicado: (2022)

Three versus five days of pivmecillinam for community-acquired uncomplicated lower urinary tract infection: A randomised, double-blind, placebo-controlled superiority trial()
por: Jansåker, Filip, et al.
Publicado: (2019)

In vitro Relative Fitness, in vivo Intestinal Colonization and Genomic Differences of Escherichia coli of ST131 Carrying bla(CTX–M–15)
por: Hertz, Frederik Boëtius, et al.
Publicado: (2022)

Effects of Antibiotics on the Intestinal Microbiota of Mice
por: Hertz, Frederik Boetius, et al.
Publicado: (2020)

Arresting chromosome replication upon energy starvation in Escherichia coli
por: Charbon, Godefroid, et al.
Publicado: (2021)

Chromosome replication as a measure of bacterial growth rate during Escherichia coli infection in the mouse peritonitis model
por: Haugan, Maria Schei, et al.
Publicado: (2018)

The efficacy of pivmecillinam: 3 days or 5 days t.i.d against community acquired uncomplicated lower urinary tract infections – a randomized, double-blinded, placebo-controlled clinical trial study protocol
por: Jansåker, Filip, et al.
Publicado: (2016)

ESBL‐production in Escherichia coli and Klebsiella pneumoniae isolates from Nigeria
por: Hertz, Frederik B., et al.
Publicado: (2019)

DNA Replication Control Is Linked to Genomic Positioning of Control Regions in Escherichia coli
por: Frimodt-Møller, Jakob, et al.
Publicado: (2016)

Emergence of linezolid-resistant Enterococcus faecium in a tertiary hospital in Copenhagen
por: Misiakou, Maria-Anna, et al.
Publicado: (2023)

Control regions for chromosome replication are conserved with respect to sequence and location among Escherichia coli strains
por: Frimodt-Møller, Jakob, et al.
Publicado: (2015)

Activating the Cpx response induces tolerance to antisense PNA delivered by an arginine-rich peptide in Escherichia coli
por: Frimodt-Møller, Jakob, et al.
Publicado: (2021)

Oxidative DNA damage is instrumental in hyperreplication stress-induced inviability of Escherichia coli
por: Charbon, Godefroid, et al.
Publicado: (2014)

Vancomycin‐resistant Enterococcus faecium: should we screen on admission?
por: Hertz, Frederik Boetius, et al.
Publicado: (2022)

Counting Replication Origins to Measure Growth of Pathogens
por: Charbon, Godefroid, et al.
Publicado: (2020)

Translocation of non-lytic antimicrobial peptides and bacteria penetrating peptides across the inner membrane of the bacterial envelope
por: Frimodt-Møller, Jakob, et al.
Publicado: (2021)

Vaginal microbiome following orally administered probiotic
por: Hertz, Frederik Boetius, et al.
Publicado: (2022)

Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review
por: Jansåker, Filip, et al.
Publicado: (2018)

Retrospective study of men with E. coli UTI treated with an oral antibiotic, and risk for a new prescription or hospital admission due to UTI
por: Jansåker, Filip, et al.
Publicado: (2020)

Within-patient horizontal transfer of pOXA-48 from a hypervirulent Klebsiella pneumoniae SL218 to Serratia marcescens following spread of the K. pneumoniae isolate among hospitalised patients, Denmark, 2021
por: Nielsen, Karen Leth, et al.
Publicado: (2023)

The Role of Efflux Pumps in the Transition from Low-Level to Clinical Antibiotic Resistance
por: Ebbensgaard, Anna Elisabeth, et al.
Publicado: (2020)

Microbiome Compositions and Resistome Levels after Antibiotic Treatment of Critically Ill Patients: An Observational Cohort Study
por: Nielsen, Karen Leth, et al.
Publicado: (2021)

Multiple DNA Binding Proteins Contribute to Timing of Chromosome Replication in E. coli
por: Riber, Leise, et al.
Publicado: (2016)

Energy Starvation Induces a Cell Cycle Arrest in Escherichia coli by Triggering Degradation of the DnaA Initiator Protein
por: Charbon, Godefroid, et al.
Publicado: (2021)

Pivmecillinam for Uncomplicated Lower Urinary Tract Infections Caused by Staphylococcus saprophyticus—Cumulative Observational Data from Four Recent Clinical Studies
por: Jansåker, Filip, et al.
Publicado: (2019)

Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort
por: Thønnings, Sara, et al.
Publicado: (2019)

The association between common urogenital infections and cervical neoplasia – A nationwide cohort study of over four million women (2002–2018)
por: Jansåker, Filip, et al.
Publicado: (2022)

The Risk of Pyelonephritis Following Uncomplicated Cystitis: A Nationwide Primary Healthcare Study
por: Jansåker, Filip, et al.
Publicado: (2022)

A Multidisciplinary Intervention to Reduce Infections of ESBL- and AmpC-Producing, Gram-Negative Bacteria at a University Hospital
por: Knudsen, Jenny Dahl, et al.
Publicado: (2014)

Horizontally acquired papGII-containing pathogenicity islands underlie the emergence of invasive uropathogenic Escherichia coli lineages
por: Biggel, Michael, et al.
Publicado: (2020)

Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial
por: Thorlacius-Ussing, Louise, et al.
Publicado: (2019)

Dogs Can Be Reservoirs of Escherichia coli Strains Causing Urinary Tract Infection in Human Household Contacts
por: Damborg, Peter, et al.
Publicado: (2023)

Antisense inhibition of the Escherichia coli NrdAB aerobic ribonucleotide reductase is bactericidal due to induction of DNA strand breaks
por: Campion, Christopher, et al.
Publicado: (2021)

Inhibition of Escherichia coli chromosome replication by rifampicin treatment or during the stringent response is overcome by de novo DnaA protein synthesis
por: Riber, Leise, et al.
Publicado: (2020)

High Rate of Per Oral Mecillinam Treatment Failure in Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Escherichia coli
por: Søraas, Arne, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tph8hqn57srsnundmoskt0vv15